4//SEC Filing
Dhingra Kapil 4
Accession 0001415889-22-006517
CIK 0001701541other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 7:05 PM ET
Size
5.4 KB
Accession
0001415889-22-006517
Insider Transaction Report
Form 4
Dhingra Kapil
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-10+15,000→ 15,000 totalExercise: $2.14Exp: 2032-06-09→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 7, 2023 or (ii) the Issuer's next annual meeting of stockholders.
Documents
Issuer
Black Diamond Therapeutics, Inc.
CIK 0001701541
Entity typeother
Related Parties
1- filerCIK 0001456849
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 7:05 PM ET
- Size
- 5.4 KB